Healthcare giant Johnson & Johnson to spin off consumer health business

Healthcare giant Johnson & Johnson to spin off consumer health business

Johnson & Johnson (JNJ) has announced plans to carve out its consumer health business into a new publicly traded company to focus on its biopharma and medical device businesses. According to the US healthcare conglomerate, the move will create two global majors that are better placed to deliver enhanced health outcomes for patients and consumers, […]

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization

Johnson & Johnson (J&J) said that the US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for Ad26.COV2.S, a single-dose COVID-19 vaccine developed by its subsidiary Janssen Pharmaceutical Companies for the prevention of COVID-19 in people aged 18 years or more. The FDA decision was driven by the totality of scientific evidence. […]

J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735

J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735

ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), which is being developed by its subsidiary – Janssen Pharmaceutical Companies. The US healthcare giant said that the ENSEMBLE vaccine trial has been initiated following positive interim results from its […]